CDC panel examines clot risk from J&J’s COVID-19 vaccine
A strange clotting problem prompted the US to temporarily halt the single-dose J&J shots last April while scientists investigated.
Full Article
CDC panel examines clot risk from J&J’s COVID-19 vaccine
Brisbane Times
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
-
CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J Shot
Newsy
-
CDC panel reviews clot risk linked to J&J's COVID-19 vaccine
SeattlePI.com
-
C.D.C. Panel Will Discuss Blood Clot Risk Linked to J.&J.’s Vaccine
NYTimes.com
-
US CDC panel to discuss limiting Johnosn and Johnson vaccine due to rare blood clot issues: Reports
newKerala.com
Advertisement
More coverage
C.D.C. Panel Is Set to Discuss Johnson & Johnson Blood Clot Risk
Officials are concerned by an increase in a rare but serious blood clotting disorder linked to the drugmaker’s vaccine. Here’s..
NYTimes.com